FDC launches stronger versions of its generic Covid drug, Favipiravir, in India

FDC launches stronger versions of its generic Covid drug, Favipiravir, in India These prescription-only drugs will be available at all retail medical outlets and hospital pharmacies across the country, from November 1, 2020, FDC said in a BSE filing. https://ift.tt/eA8V8J

Comments

Popular posts from this blog

SC transfers PIL seeking implementation of law on mental health care to NHRC

Hospital-insurer conflict: Will latest circular by NMC help in reducing the pain of health insurance policyholders?

Over 9.19 crore hospital admissions facilitated under Ayushman Bharat since 2018